Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53

Prophylactic and therapeutic antileukemic effects induced by the AAC-11-derived Peptide RT53

Despite considerable progress, the treatment of acute leukemia continues to be a challenge for a significant majority of patients. Using a well-characterized preclinical mouse model of acute promyelocytic leukemia (APL), we evaluated here the antileukemic efficacy of RT53, an anticancer peptide with...

Full description

Bibliographic Details
Main Authors: Justine Habault, Anna Kaci, Ewa Pasquereau-Kotula, Claire Fraser, Christine Chomienne, Hervé Dombret, Thorsten Braun, Marika Pla, Jean-Luc Poyet
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
anticancer peptide
acute leukemia
autologous tumor cell vaccine
tumor immunity
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1728871

Internet

http://dx.doi.org/10.1080/2162402X.2020.1728871

Similar Items